Skip to main content

and
  1. No Access

    Article

    Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience

    Triplet-drug regimen bortezomib–thalidomide–dexamethasone (VTD) and bortezomib–lenalidomide–dexamethasone (VRD) are considered as standard of care induction prior autologous stem-cell transplantation (ASCT) in...

    Vanille Laurent, Clémentine Fronteau, Chloé Antier in Bone Marrow Transplantation (2021)